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Abstract
Background: Post-operative pulmonary infection often appears to result from aspiration of pathogens colonizing the
oral cavity. It was hypothesized that impaired periodontal status and pathogenic oral bacteria significantly contribute to
development of aspiration pneumonia following neurosurgical operations. Further, the prophylactic effects of a single
dose preoperative cefazolin on the oral bacteria were investigated.
Methods: A matched cohort of 18 patients without postoperative lung complications was compared to 5 patients who
developed pneumonia within 48 hours after brain surgery. Patients waiting for elective operation of a single brain tumor
underwent dental examination and saliva collection before surgery. Bacteria from saliva cultures were isolated and
periodontal disease was scored according to type and severity. Patients received 15 mg/kg cefazolin intravenously at the
beginning of surgery. Serum, saliva and bronchial secretion were collected promptly after the operation. The minimal
inhibitory concentrations of cefazolin regarding the isolated bacteria were determined. The actual antibiotic
concentrations in serum, saliva and bronchial secretion were measured by capillary electrophoresis upon completion of
surgery. Bacteria were isolated again from the sputum of postoperative pneumonia patients.
Results: The number and severity of coexisting periodontal diseases were significantly greater in patients with
postoperative pneumonia in comparison to the control group (p = 0.031 and p = 0.002, respectively). The relative risk
of developing postoperative pneumonia in high periodontal score patients was 3.5 greater than in patients who had low
periodontal score (p < 0.0001). Cefazolin concentration in saliva and bronchial secretion remained below detectable
levels in every patient.
Conclusion: Presence of multiple periodontal diseases and pathogenic bacteria in the saliva are important predisposing
factors of postoperative aspiration pneumonia in patients after brain surgery. The low penetration rate of cefazolin into
the saliva indicates that its prophylactic administration may not be sufficient to prevent postoperative aspiration
pneumonia. Our study suggests that dental examination may be warranted in order to identify patients at high risk of
developing postoperative respiratory infections.
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Patients requiring a prolonged surgical procedure with
mechanical respiratory support frequently develop post
operative or ventilator-associated pneumonia that
increases morbidity, mortality and length of recovery [1-
6]. While several different routes have been suggested, in
most cases the pulmonary infection appears to result from
aspiration of pathogens colonizing the oral cavity. How-
ever, there is still some discussion about the definitive evi-
dence of a causal relationship between oral pathogens and
post-operative pneumonia [7,8]. The human saliva har-
bors abundant bacterial flora [6,9,10] and aspiration of
saliva containing pathogenic bacteria can lead to pneu-
monia [11-14].
Aspiration pneumonia-associated mortality is one of the
most serious problems in elderly patients [15,16]. Hospi-
tal inpatients that undergo endotracheal intubation for
long surgical procedures are also at increased risk of aspi-
ration [17,18]. In neurosurgical patients, aspiration of
oropharyngeal secretions can be facilitated by leakage
around the endotracheal tube cuff, weakness of pharyn-
geal and coughing reflexes, impaired level of conscious-
ness, and postoperative immobilization [7].
Poor oral hygiene and periodontal disease can increase
the proliferation of pathogenic bacteria many of which
can cause aspiration pneumonia. Indeed Inglis et al.
[19,20] reported that the major factor in the development
of pneumonia was not the type but the amount of bacteria
aspirated. An increase in the number of oral pathogenic
species has been demonstrated in elderly persons requir-
ing nursing care [15,16]. Furthermore, professional oral
care has been shown to reduce this number [21] and oral
care decreased frequency of fever [22,23] and mortality
rate from pneumonia in the elderly [23-25].
The therapeutic benefits of the first and second generation
cephalosporins have been thoroughly investigated and
their wide spectrum of efficacy distinguishes them from
other antibiotics for perioperative prophylaxis [26-29].
Administration of cephalosporins for surgical procedures
is a common practice for the prevention of infections, but
the chosen antibiotic varies. We have previously found
that after a single intravenous dose, a number of cepha-
losporins failed to accumulate in the saliva and sputum of
patients at high concentrations, indicating insufficient
local antibacterial coverage [30,31].
Here we investigated the cefazolin levels in serum, saliva
and bronchial secretions postoperatively and compared
them with the MIC of a range of bacteria isolated from the
oral cavity of the patients. We also investigated whether a
correlation exists between bacterial sensitivity to cefazolin
and development of post-operative pneumonia. We
hypothesized that presence and severity of periodontal
disease increases the risk of oral pathogen aspiration dur-
ing brain surgery in this population. In this study we
aimed to clarify the importance of assessing periodontal
status before neurosurgical procedures on older patients
in order to identify those at high risk for developing post-
operative pneumonia.
Methods
Patient recruitment
All procedures were approved by the Ethical Committee
of the University of Debrecen, Hungary and every patient
signed an Informed Consent Form prior to recruitment to
the study. Patients recruited into the study were non-
smokers, aged older than 60 years and were diagnosed
with the presence of an intracranial solitary extraaxial
supratentorial tumor, Glasgow Coma Scale (GCS) 15;
scheduled for elective routine craniotomy and tumor
removal between January 2006 and August 2007 on the
Neurosurgical Department of the University of Debrecen.
Morbidly obese patients, smokers and who had diabetes
mellitus, alcohol abuse, any immune deficiency, preexist-
ing pulmonary conditions (e.g. chronic obstructive pul-
monary disease, COPD), heart insufficiency and in whom
prompt postoperative extubation could not be anticipated
or neurological complications appeared, were excluded
from the study. The recruited patients had normal preop-
erative chest X-ray and their laboratory parameters were in
the physiological range. Patients had no lower cranial
nerve palsy, so they had normal gag and coughing
reflexes. Only those patients were recruited finally in the
study that had no changes in the neurological status after
the operation. The perioperative feeding status of each
recruited patient remained normal as well. All patients
were observed and treated in the Intensive Care Unit of
the Neurosurgical Department after surgery.
Following brain surgery a cohort of eighteen sex- (Figure 1A),
age- (Figure 1B), tumor type (Figure 1A), weight- (Figure 1C)
and operation-time (Figure 1D) matched patients without
postoperative lung complications (control group) were com-
pared to five patients having postoperative aspiration pneu-
monia developed within 48 hours after surgery (pneumonia
group) (Figure 1). Pneumonia was diagnosed based on the
guidelines of the American Thoracic Society by X-ray (new or
progressive radiographic infiltrate), new onset of fever (body
temperature = 38.0°C), symptoms of coughing with puru-
lent sputum, chest pain and leukocytosis (white blood cell
count > 10.0 G/L) [32]. Sputum samples were collected from
pneumonia patients for bacterial culture by a pulmonolo-
gist. Patients diagnosed with pneumonia were treated
promptly with ceftriaxone 80 mg/kg/24 hour followed by
treatment with the appropriate antibiotic according to the
results of the antibiotic susceptibility tests obtained from the
bacterial cultures.Page 2 of 10
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BMC Infectious Diseases 2009, 9:104 http://www.biomedcentral.com/1471-2334/9/104Dental examination
Preoperative dental examinations were performed by the
same experienced dentist on each patient awaiting neuro-
surgical procedures. In order to be able to quantify the
severity of the periodontal disease in patient populations,
a numeric scoring system based on commonly accepted
disease severity definitions for evaluation of periodontal
diseases was established. Periodontal conditions of the
patients were categorized in five main diagnoses that were
each given a numeric score. The following five conditions
were diagnosed in the patients: Dental calculus: score „3”
(presence of visible calcified deposit around the teeth);
Chronic gingivitis: score „4” (redness and swelling around
the gum without loss of connective tissue attachment).
Mild periodontitis: score „5” (periodontal site with 3 mil-
limeters of attachment loss and 4 millimeters of pocket
depth). Moderate periodontitis: score „6” (teeth with inter-
proximal attachment loss of 4 millimeters OR teeth with
5 millimeters of pocket depth at interproximal sites).
Severe periodontitis: score „7” (teeth with interproximal
attachment loss of 6 millimeters or more AND at least one
tooth with 5 millimeters or more of pocket depth at inter-
proximal sites). The "Disease Score" was then calculated
as the sum of the scores of co-existing periodontal diseases
in a patient (possible range: 0–25). In addition, patients
received a "Severity Score", which equaled the number of
their co-existing periodontal diseases (possible range: 0–
5). For example a patient with dental calculus and mild
periodontitis would have a Disease score of 8 and a Sever-
ity score of 2.
Clinical parameters of patientsFigure 1
Clinical parameters of patients. Patients that developed pneumonia had comparable age, weight and duration of operation 
to controls that had no postoperative pneumonia. (A): Patients demographic data in a table format. (B-C): The patients who 
developed postoperative pneumonia were matched according to sex, age, weight and length of brain surgery. Data were com-
pared using the non-parametric Mann-Whitney test and expressed as "box and whiskers: 10–90 percentile".
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for bacterial cultures. Bacterial strains were isolated preop-
eratively from the saliva of the patients and the minimal
inhibitory concentrations (MIC) of cefazolin for each of
the saliva-derived bacterial strains were determined.
Determination of MIC
The MIC of cefazolin was determined with a standard
broth microdilution method according to the guidelines
of Clinical and Laboratory Standards Institute (CLSI) [33].
Cefazolin was diluted in sterile distilled water [34]. The
interpretation criteria were in accordance with those sug-
gested by the CLSI.
Drug administration and postoperative sample collection
A single dose of cefazolin (15 mg/kg) was given intrave-
nously to patients just prior to skin incision. Following
the surgical procedures to safely reverse the muscle relax-
ant (rocuronium), patients received 0.015 mg/kg neostig-
mine and 0.0075 mg/kg atropine. Bronchial secretions
were also aspirated from the trachea with a sterile suction-
pipe through the endotracheal tube. Every patient recov-
ered without severe neurological symptoms and GCS
above 13 and was extubated promptly after the operation.
During extubation, serum samples were obtained and
saliva samples were collected from the pharynx above the
cuff of the endotracheal tube.
The concentrations of cefazolin in the serum, saliva and
bronchial secretion were determined and the levels of
cefazolin were compared to the MIC values of the bacteria
isolated preoperatively from the saliva. Bacteria were iso-
lated again from the sputum of the five patients in whom
postoperative pneumonia developed 48 hours after brain
surgery. Sputum samples were carefully collected before
ceftriaxone administration by a pulmonologist with a
sterile suction-tube to avoid oral contamination. The iso-
lated bacteria were compared to the bacteria isolated
before the operation from the saliva of the same patients.
Capillary electrophoresis
Serum, saliva, and bronchial secretion samples were
stored at -20°C until analysis was performed. The concen-
tration of cefazolin was determined by capillary electro-
phoresis as described previously [35]. Electrophoretic
runs were performed no later than 4 hours after sample
preparation. The optimal separation conditions for the
determination of different cephalosporin concentrations
using capillary electrophoresis were the subject of our ear-
lier study [36,37]. The capillary electrophoresis instru-
ment used in the current study was a CE3D model
(Agilent, Waldbronn, Germany).
Statistical analysis
Data from a cohort of control (n = 18) and pneumonia (n
= 5) patients were compared using the non-parametric
Mann-Whitney test. Unless otherwise stated, data were
expressed as median and interquartile range. Correlations
were made using regression analysis. Odds ratios were cal-
culated using contingency table and the Chi-square test;
one-sided p value was calculated. A p value of < 0.05 was
accepted as significant.
Results
Patients that developed pneumonia had comparable age,
weight and duration of operation to controls. The final
patient selection included 23 patients. The average age
was 70.4 ± 5.9 years (mean ± SD), the average weight was
76.9 ± 12.5 kg (mean ± SD). The duration of the brain sur-
gery ranged between 105 and 171 minutes of the recruited
patients, with an average of 140.2 ± 19.7 minutes (mean
± SD).
Five patients who developed postoperative aspiration
pneumonia (pneumonia group) were compared to eight-
een patients without postoperative lung complications
(control group) for their preoperative periodontal status,
oral bacterial profile, cefazoline MIC value of the isolated
bacteria and cefazolin concentration in the serum, saliva
and bronchial secretion at time of extubation after sur-
gery. The two patient groups we studied were carefully
matched for sex, age, weight, histological diagnosis of the
brain tumor and duration of operation (Figure 1).
Presence of periodontal disease and disease severity were
significantly greater in patients with postoperative pneu-
monia. Currently used methods to assess periodontal sta-
tus may not accurately reflect a risk for aspiration
pneumonia. We established five different main periodon-
tal diagnoses in patients waiting for neurosurgery, and
scores were assigned to each diagnosis. Both the Disease
Score (Figure 2A) and the Severity score (Figure 2B) was
significantly elevated in patients who developed postop-
erative aspiration pneumonia (p = 0.0018 and p = 0.031,
respectively).
To calculate the risk of pneumonia, we divided the
patients into a "High periodontal score" (Disease Score ≥
15, Severity score ≥ 3) and a "Low periodontal score"
group (Disease Score < 15, Severity score < 3). Analysis of
the relative risk revealed that the "High periodontal score"
patients had a significantly greater chance to develop
pneumonia than the "Low periodontal score" patients (p
< 0.0001, relative risk: 3.5 (confidence interval [95%]:
1.085 to 11.29) (Figure 2C).
Cefazolin levels were measured by capillary electrophore-
sis. Figure 3A shows the distribution of isolated bacteria
according to their MIC values. While Gram positive bacte-
ria predominated in most of the patients, Gram negative
bacteria were also isolated from the oral cavity, several of
which showed resistance for cefazolin (Figure 3B).Page 4 of 10
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BMC Infectious Diseases 2009, 9:104 http://www.biomedcentral.com/1471-2334/9/104Presence of these "high MIC" bacteria was found in both
the control and pneumonia groups and there was no rela-
tionship between the maximal MIC needed for bacterial
coverage and development of postoperative pneumonia
in the individual patients. High serum cefazolin levels
(Figure 3C) did not correspond to cefazolin measured in
the saliva. In fact the antibiotic levels in all the saliva sam-
ples were below the detection level, 0.5 mg/L (marked by
a vertical dashed line in Figure 3A) indicating a low pene-
tration of this antibiotic into the saliva. When serum
cefazolin concentrations were compared between control
and pneumonia patients (Figure 3C) we found no signifi-
cant difference suggesting that there was no relationship
between circulating cefazolin levels and presence of pneu-
monia after brain surgery.
The same cefazolin resistant Gram negative bacteria were
isolated from the saliva pre-operatively and the sputum of
the patients who developed postoperative pneumonia. In
order to determine whether adequate serum cefazolin
concentrations were achieved against the pathogenic bac-
teria in the pneumonia patients, we calculated the serum
cefazolin/MIC ratio (using the MIC that was determined
for the bacteria isolated from the sputum) in each of the
patients. To provide adequate antibacterial protection,
this value should ideally be greater than 1. Although cir-
culating cefazolin/MIC ratios appeared adequate, the
same ratios for the saliva of the patients were significantly
below 1 (Figure 4D). In addition, comparison of the
serum cefazolin/MIC ratio between control and pneumo-
nia patients showed no difference (not shown).
Discussion
In this study we investigated the significance of periodon-
tal diseases in postoperative pneumonia and the effects of
preoperative cefazolin prophylaxis on the oral pathogen
flora in older patients after neurosurgical operation. Our
results showed that the same pathogenic Gram negative
bacteria isolated from the sputum of pneumonia patients
were also isolated pre-operatively from the saliva suggest-
ing aspiration etiology. There was no association between
the type of bacteria isolated, their cefazolin sensitivity or
the cefazolin serum levels and development of postopera-
tive pneumonia. However, the severity of periodontal dis-
ease of the patients appeared a significant risk factor for
postoperative pneumonia. Our study emphasizes the
importance of preoperative oral health assessment and
identification of patients at risk as this type of pneumonia
can be prevented by proper care.
Relative risk for postoperative pneumonia in relation to periodontal diseasesFigure 2
Relative risk for postoperative pneumonia in relation to periodontal diseases. Presence of periodontal diseases and 
disease severity were significantly greater in patients with postoperative pneumonia. (A-B): Data were expressed as "box and 
whiskers: 10–90 percentile" and compared using the non-parametric Mann-Whitney test (A): Disease score: periodontal dis-
eases in every patient were evaluated. A score number was ordered to each diagnose, and the sum of the scores appears as 
"disease score". * = p = 0.0018 (B): Severity score is the number of co-existing periodontal diseases in each patient. * = p = 
0.031; (C): Analysis of Relative Risk: "High score" patients had a Disease Score of ≥ 15 and a Severity Score of ≥ 3. Number of 
patients is shown in each groups. Chi-square test was performed, one-sided p value was calculated. *p < 0.0001; Relative risk: 
3.5; confidence interval (95%): 1.085 to 11.29.
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BMC Infectious Diseases 2009, 9:104 http://www.biomedcentral.com/1471-2334/9/104Bacterial bronchopneumonia is one of the most common
infectious diseases in adults, with a well-known high mor-
bidity and mortality, especially in old patients [38-40]. In
a large-scale European study pneumonia accounted for
approximately 50% of all intensive care unit (ICU) infec-
tions which significantly increased ICU death [41].
Although multiple risk factors are identified, the single
most important one has been considered to be intubation
[42]. Pneumonia also often appears as a postoperative
complication after various surgical procedures [43,44].
Pneumonia can develop in surgical patients without pre-
vious lung disease or brain damage [18], but risk for aspi-
ration is higher in older patients [17]. Further, age, sex,
obesity, preoperative hospital stay, smoking, chronic
obstructive pulmonary disease, other preexisting pulmo-
nary conditions, type and duration of surgery and
anesthesia, and nasogastric tube placement would each be
considered a significant risk factor [44]. While aspiration
of oral bacteria is one of the main etiologic factors in
developing pneumonia in hospitals [3,45] the signifi-
cance of existing periodontal disease is not completely
clarified. In this study we selected elderly patients, >60
years of age, since periodontal diseases are known to be
very common in this age group and there are often patho-
genic bacteria identified in their saliva. Furthermore, after
identification of the pneumonia patients, age, sex, weight,
duration and type of operation were matched with the
control group for comparison of their periodontal status.
Patients, who underwent cranial operations, were selected
for investigation. As opposed to abdominal surgery, brain
surgery is considered "clean", without open exposure to
Minimal inhibitory concentrations (MIC) of cefazolin and its concentration in serumFigure 3
Minimal inhibitory concentrations (MIC) of cefazolin and its concentration in serum. Neither cefazolin sensitivity 
of the bacteria isolated from the saliva/bronchial secretions nor serum cefazolin levels were different between control and 
pneumonia patients. Bacteria were isolated from the saliva pre- and postoperatively. Bronchial secretion and serum were 
obtained post-operatively for bacterial culture and determination of cefazolin levels. (A): Distribution of isolated bacteria 
according to their MIC values. The antibiotic level of all the saliva and bronchial secretion samples fell below 0.5 mg/L; marked 
by the vertical dashed line. (B): Distribution of isolated bacteria according to percentage of patients with that particular species 
in each group. (C): Serum cefazolin levels are expressed as "box and whiskers: 10–90 percentile" and compared using the non-
parametric Mann-Whitney test between control and pneumonia patients (n = 18 and 5, respectively).
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is particularly suitable to investigate the importance of
enteral bacteria from the oral cavity and upper airways, in
development of postoperative pneumonia. During long
surgical procedures, saliva and oropharyngeal secretions
accumulate in the pharynx above the cuff of the tube used
for intratracheal ventilation. These secretions may then be
aspirated because function of the lower cranial nerves can
be impaired and so pharyngeal and coughing reflexes
return slowly in this patient population. Additionally, the
low level of consciousness and prolonged immobilization
period after cranial surgery are all important factors in
aspiration of saliva and oropharyngeal secretions and can
increase the likelihood of developing pulmonary compli-
cations [47,48]. Thus, verification of the importance of
aspiration etiology and the ability to identify patients who
are at increased risk to develop postoperative pneumonia
has a particularly high clinical importance in neurosurgi-
cal patients.
Although several methods for evaluation of oral hygiene
were reported [49,50] problems in reliability and validity
have also been noted [51]. The currently used methods to
assess periodontal status range from simple visual evalua-
tion of presence or absence of tongue coating [52]
through manual probing [53] to elaborate bacterial cul-
tures or sophisticated molecular biology techniques [54].
In our study a quantitative scoring assessment was estab-
lished using generally accepted visual diagnosis and man-
ual probing [55]. Presence of Dental calculus, Chronic
gingivitis, Mild periodontitis, Moderate periodontitis and
Severe periodontitis were diagnosed. The "Disease Score"
Comparison of the minimal inhibitory concentration (MIC) of cefazolin regarding the bacteria isolated preoperatively from the saliva nd postoperatively from the sputumFigure 4
Comparison of the minimal inhibitory concentration (MIC) of cefazolin regarding the bacteria isolated preop-
eratively from the saliva and postoperatively from the sputum. Cefazolin resistant pathogenic, Gram negative bacteria 
isolated from the saliva pre-operatively, were also grown from the sputum of the postoperative pneumonia patients. The verti-
cal axis of the graphs crosses the x axis at 0.5 mg/L. The antibiotic level of all the sputum samples fell below 0.5 mg/ml. The 
bars indicate the MIC value of bacteria obtained pre-operative from the saliva. Black bars denote the bacteria that were cul-
tured from both the sputum and the saliva of the same patient.
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conditions. In addition, patients received a Severity Score
showing the number of their co-existing conditions.
Based on these scores we divided the patients into a "High
periodontal score" and a "Low periodontal score" group.
Our results showed that the "High periodontal risk"
patients had a significantly greater chance to develop
pneumonia than the "Low periodontal risk" patients indi-
cating that presence of severe periodontal diseases predis-
posed to postoperative pneumonia in our patient
population. Furthermore, our periodontal scoring system
appeared to have a good predictive value based on the cal-
culated sensitivity (0.8889; CI [95%]: 0.6529 to 0.9862),
specificity (1.000; CI [95%]: 0.4782 to 1.000), positive pre-
dictive value (1.000; CI [95%]: 0.7941 to 1.000) and nega-
tive predictive value (0.7143; CI [95%]: 0.2904 to 0.9633).
Regarding the low n however, further validation of our
scoring system is needed in a larger clinical trial. Neverthe-
less, these results confirmed that evaluation of periodon-
tal status using a relatively simple visual scoring system
may identify patients with high risk for developing post-
operative pneumonia. Indeed, Gram negative bacteria iso-
lated from the saliva of patients with high periodontal
score before surgery, were also grown from the sputum
after they developed pneumonia post-operatively, further
suggesting that the infectious organisms originated from
the oropharyngeal region.
These results also indicated that infection occurred in
spite of cefazolin pretreatment in the pneumonia patients.
The antibiotics most appropriate for prophylaxis of post-
operative infections depend on the nature of the opera-
tion [56,57]. In aseptic (clean) operations, such as brain
surgery, Gram-positive postoperative infections are the
primary concern, and cefazolin has been recommended
because of its excellent pharmacokinetics and good activ-
ity against Gram-positive pathogens, including staphylo-
cocci [46]. Although Gram negative bacteria are in general
resistant to cefazolin it can be used also against some of
them [30,47,57,58]. Single-injection prophylaxis given at
the time of induction of anesthesia is effective, inexpen-
sive, has relatively few side effects and does not induce
bacterial resistance [46]. Concentrations of cefazolin
measured in the saliva and sputum of the patients, simi-
larly to our previous studies, indicated a very low penetra-
tion rate [30,31]. Thus, while circulating cefazolin levels
appeared adequately high (corresponding to the highest
MIC values measured in the oral bacterial cultures), the
cefazolin levels in the saliva and bronchial secretions of
the patients fell below 0.5 mg/L. In our two patient groups
we could find no significant differences between the
cefazolin levels of the serum, saliva or bronchial secre-
tions. Furthermore, there were no differences in the type
of bacteria isolated or the sensitivity of these bacteria to
cefazolin between the control and the pneumonia groups.
It is noteworthy that the causative agents isolated from the
sputum of patients, Acinetobacter baumanii, Pseudomonas
aeruginosa, Klebsiella pneumoniae and Escherichia coli, had a
relatively high cefazolin MIC (2–64 < mg/L). In contrast,
the MIC of a number of species including Staphylococcus
aureus, Haemophilus influenzae and most Streptococci fell
around or below 0.5 mg/L indicating high sensitivity of
these bacteria to cefazolin. It is possible therefore that
cefazolin even at very low concentrations, affected the oral
bacterial flora by suppressing the sensitive species. This in
turn may have resulted in an overgrowth of the more
resistant, Gram negative species, aspiration of which led
to pneumonia in the susceptible patients. Our speculation
is supported by the fact that skewing of the oral bacterial
flora in the favor of the pathogenic Gram negative organ-
isms can predispose to development of nosocomial pneu-
monia [59].
Even though pathogenic, Gram negative bacteria were iso-
lated from the saliva of almost all patients we investigated;
only those with severe periodontal disease developed
pneumonia. Indeed it appears that the amount of bacteria
aspirated plays a major pathogenic role in intubated
patients [19]. Although we did not perform quantitative
assessment of the bacteria isolated from the saliva of the
patients, it is likely that more severe periodontal diseases
are associated with a larger number of oral bacteria.
Reduction of bacterial number by topical treatment there-
fore may be an attractive therapeutic choice for patients at
high risk. For instance, use of chlorhexidine gluconate in
the early post-intubation period was shown to mitigate or
delay the development of ventilator-associated pneumo-
nia [8,60-63]. Further, treatment of mechanically venti-
lated patients with a daily oral hygiene consisting of an
0.12% chlorhexidine gluconate wash reduced the risk for
nosocomial pneumonia [63-65].
Conclusion
Taken together, our study suggests that periodontal
screening and a quantitative assessment of disease status
is a useful method to identify patients at high risk of
developing postoperative pneumonia. This measure is
particularly important in elderly patients who commonly
suffer from periodontal diseases. Based on our results a
preoperative dental investigation and therapy for decreas-
ing periodontal lesions is suggested in high risk patients in
case of elective operation. Further studies to evaluate the
role of bacterial load in the oral cavity and the effective-
ness of topical treatment for prevention postoperative res-
piratory infections should be considered.Page 8 of 10
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